|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: CARACO PHARMACEUTICAL LABORATORIES LTD, 10QSB, EX-4, 2000-08-14 |
Next: GLOBAL OPPORTUNITY FUND LP, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 549,144
<SECURITIES> 0
<RECEIVABLES> 489,483
<ALLOWANCES> 145,000
<INVENTORY> 1,520,896
<CURRENT-ASSETS> 2,634,983
<PP&E> 11,386,797
<DEPRECIATION> 4,149,084
<TOTAL-ASSETS> 9,872,696
<CURRENT-LIABILITIES> 12,092,922
<BONDS> 0
0
1,000,000
<COMMON> 0
<OTHER-SE> (46,729,853)
<TOTAL-LIABILITY-AND-EQUITY> 9,872,696
<SALES> 1,355,432
<TOTAL-REVENUES> 1,355,432
<CGS> 1,378,382
<TOTAL-COSTS> 1,378,382
<OTHER-EXPENSES> (2,775,511)
<LOSS-PROVISION> 145,000
<INTEREST-EXPENSE> (733,214)
<INCOME-PRETAX> (3,508,724)
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,508,724)
<EPS-BASIC> (0.18)
<EPS-DILUTED> (0.18)
</TABLE>
|
|